Clinical Trials Browser

Phase 1 × Neuroendocrine Tumors × Lutetium-177 × Clear all

NCT05249114 2025-03-10

Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors

Phase 1 Active not recruiting

Neuroendocrine Tumors